• Guidance

Cell-cultivated products: Regulatory authorisation

Content: Guidance

Introduction

Cell-cultivated products are foods made without slaughtering animals or using traditional farming and agricultural practices. To make them, you grow cells isolated from animals or plants, including cells from meat, seafood, fat, offal, or fertilised eggs are grown in a controlled environment, then harvest them to make a final food product. 

The Food Standards Agency (FSA) and Food Standards Scotland (FSS) are running the Cell-Cultivated Products Sandbox Programme from February 2025 to February 2027. Through this programme, we’re building our understanding of cell-cultivated products so we can produce guidance on a range of related. As we learn more, we’ll publish further guidance to help you understand how food regulations apply to your products. This may include updates to guidance we’ve already published.   

If you’re an innovative food business, you might not be familiar with the regulated products framework. This guidance explains how the framework’s requirements apply to cell-cultivated products, so you can understand and correctly apply them when producing cell-cultivated products, and make informed choices about their regulatory strategies.

Intended audience

This guidance is for anyone involved in producing cell-cultivated products from animal cells for human consumption. From this point on, we use ‘cell-cultivated products’ to mean only those made from animal cells.

This guidance applies to businesses based in:

  • England and Wales, where the FSA is the food safety authority
  • Scotland, where FSS is the food safety authority

This guidance does not apply to businesses based in Northern Ireland, which remains aligned with EU legislation.

European Union Sanitary and Phytosanitary (SPS) context

The UK is currently negotiating a SPS agreement with the EU. The agreement will affect the role FSA and FSS play in the authorisation of regulated products. 

The regulated products framework in GB is the same as the one used in the EU. 

This means that this guidance will be relevant for any cell-cultivated product businesses considering applying to either the GB or EU market authorisation systems, regardless of the outcome of the SPS agreement.

Review

This guidance is accurate as at the date of publication. 

We review our guidance regularly to keep it up to date and relevant. We’ll review this guidance again by 30 2027. 

Contact us

If you have feedback on this guidance, contact:  

Did you find this helpful? We would love to hear from you.
Thank you for your feedback!